Almeida Capital is pleased to be a premier sponsor of AltAssets
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

Click here for printer friendly page

Weekly Deals and Funds Roundup: 6 September 2006

06/09/2006Source: AltAssets.  

Click here for the latest news, views and interviews in the clean energy investor communityA selection of the latest deals and funds news from across the globe - essential reading for those who need to keep up-to-date with the industry's key developments.

This weekly roundup provides an update on deals and fund activity that did not feature as separate stories in AltAssets' daily news service.

DEALS

Innova 3, a private equity investment fund managed by Innova Capital, has sold its shares in Polish loan broker Dom Finansowy QS. The shares have been purchased by LaSer Group. Innova Capital invested in Dom Finansowy QS at the end of 2004, purchasing 75 per cent of the company's shares.

Sybase, a provider of enterprise infrastructure and mobile software, has agreed to acquire Chantilly, Virginia-headquartered Mobile 365, a specialist in mobile messaging and content delivery, in an all cash transaction. The purchase price set forth in the definitive agreement is $425m, which is subject to adjustment based on Mobile 365's working capital as of the closing date. Net of acquired cash, the transaction is valued at approximately $400m. Mobile 365 is privately held and backed by venture capital firms including Draper Fisher Jurvetson, Draper Atlantic Venture, 3i Technology Partners, Institutional Venture Partners and Mayfield.

TMP Worldwide Advertising & Communications, a North American recruitment advertising agencies, has announced that Monster Worldwide has approved a definitive agreement to sell the company to its senior management team and VSS Mezzanine Partners, an investment fund managed by Veronis Suhler Stevenson. The purchase price of the transaction is $45m.

Caden Biosciences, a life sciences tools and services company developing assays for the high-throughput screening of allosteric modulators of G-Protein Coupled Receptors, has closed on a Series A preferred stock financing led by Baird Venture Partners, the US-based venture capital affiliate of investment firm Robert W. Baird & Co. BVP was joined in the financing by new investors including Venture Investors, The State of Wisconsin Investment Board and IllinoisVENTURES, as well as existing investor Vanderbilt University.

FUNDS

Pangaea Ventures has held a first closing on Pangaea Ventures Fund II. Lead investors are BASF, Solvay and Ciba Specialty Chemicals. Pangaea Ventures is focused on advanced materials and specialty chemicals, including energy technology, environmental technology and nanotechnology. Additional closings are expected in the next few months for the proposed $50m fund.

Copyright © 2006 AltAssets

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter